Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors
- Status
- COMPLETED
- Phase
- PHASE1
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
- Status
- UNKNOWN
- Phase
- PHASE2
MRD-guided Treatment in NPM1mut AML Patients
- Status
- TERMINATED
- Phase
- PHASE2
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
- Status
- RECRUITING
- Phase
- NA
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Trial of Pembrolizumab in Cancer of Unknown Primary
- Status
- COMPLETED
- Phase
- PHASE2
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2